You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HRZE

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Pulmonary Tuberculosis TB in Sputum: (+) Microscopy Trial in Shanghai (Group A (the standard 2HRZE/4HR regimen), Group B (New

Completed
  • Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
  • Group A (the standard 2HRZE/4HR regimen）
  • Group B (New short course PRS regimen, 4EZ(high dose)PtoCfz)
  • Shanghai, China
  • +3 more
Nov 5, 2020

Tuberculosis, Pulmonary Trial in Groningen (Azithromycin 250 mg)

Recruiting
  • Tuberculosis, Pulmonary
  • Azithromycin 250 mg
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 7, 2022

Tuberculosis Trial in Paris (PCR-based strategy, conventional therapy)

Completed
  • Tuberculosis
  • PCR-based strategy
  • conventional therapy
  • Paris, France
  • +1 more
Mar 17, 2020

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Tuberculosis Trial in Mozambique, South Africa, Tanzania (Sutezolid, N-acetyl cysteine, Pretomanid)

Not yet recruiting
  • Tuberculosis
  • Maputo, Mozambique
  • +3 more
Jan 13, 2023

Tuberculosis Trial in Johannesburg (Pravastatin)

Completed
  • Tuberculosis
  • Johannesburg, South Africa
    Chris Hani Baragwanath Hospital
Sep 26, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

Completed
  • Tuberculosis
  • Meropenem Injection
  • +4 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jan 24, 2022

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
Has Results
  • Tuberculosis
  • San Francisco, California
  • +32 more
Sep 1, 2021

Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

Completed
  • Pulmonary Tuberculosis
  • Meropenem 6g IV over 6 hours
  • +9 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 31, 2023

Tuberculous Meningitis Trial in China (Isoniazid)

Unknown status
  • Tuberculous Meningitis
  • Beijing, China
  • +3 more
Jan 28, 2021

Tuberculosis Trial in Addis Ababa (MERM-observed self-administered therapy)

Completed
  • Tuberculosis
  • Electronic pillbox-enabled SAT
  • Addis Ababa, Ethiopia
    Addis Ababa University, College of Health Sciences
Sep 16, 2021

Tuberculosis, Pulmonary Trial in China (Interleukin-2)

Recruiting
  • Tuberculosis, Pulmonary
  • Fuyang, Anhui, China
  • +15 more
Feb 20, 2021

Pulmonary Tuberculosis Trial in Bellville, Mowbray (Linezolid, HRZE (isoniazid rifampicin,pyrazinamide,ethambutol))

Completed
  • Pulmonary Tuberculosis
  • Linezolid
  • HRZE (isoniazid rifampicin,pyrazinamide,ethambutol)
  • Bellville, Cape Town, South Africa
  • +1 more
Jan 10, 2019

Four Months Moxifloxacin Containing Daily Regimen Study Among

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Chennai, Tamilnadu, India
    National Institute for Research in Tuberculosis
Sep 29, 2021

Tuberculosis, Pulmonary Trial in Mbeya (N-acetyl cysteine)

Recruiting
  • Tuberculosis, Pulmonary
  • N-acetyl cysteine
  • Mbeya, Tanzania
    NIMR-Mbeya Medical Research Centre
Jan 18, 2021

Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant Trial in Worldwide (Moxifloxacin, PA-824,

Completed
Has Results
  • Tuberculosis, Pulmonary, Drug Sensitive
  • Tuberculosis, Pulmonary, Multi Drug-resistant
  • Tbilisi, Georgia
  • +25 more
Mar 1, 2019